151 related articles for article (PubMed ID: 8960834)
1. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.
McCormack LJ; Nagi DK; Stickland MH; Mansfield MW; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetologia; 1996 Dec; 39(12):1512-8. PubMed ID: 8960834
[TBL] [Abstract][Full Text] [Related]
2. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
[TBL] [Abstract][Full Text] [Related]
3. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.
Panahloo A; Mohamed-Ali V; Lane A; Green F; Humphries SE; Yudkin JS
Diabetes; 1995 Jan; 44(1):37-42. PubMed ID: 7813812
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor (PAI-1) and non-insulin-dependent diabetes in Pima Indians, south Asians and Europeans. Populations at varying risk of NIDDM and coronary artery disease.
Nagi DK; Knowler WC; Hanson RL; Ali VM; Yudkin JS
Thromb Haemost; 1996 Jun; 75(6):921-7. PubMed ID: 8822587
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
7. Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus.
Mansfield MW; Stickland MH; Grant PJ
Thromb Haemost; 1995 Sep; 74(3):842-7. PubMed ID: 8571308
[TBL] [Abstract][Full Text] [Related]
8. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes.
Mansfield MW; Stickland MH; Grant PJ
Thromb Haemost; 1995 Oct; 74(4):1032-4. PubMed ID: 8560407
[TBL] [Abstract][Full Text] [Related]
11. Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians.
Majer M; Mott DM; Mochizuki H; Rowles JC; Pedersen O; Knowler WC; Bogardus C; Prochazka M
Diabetologia; 1996 Mar; 39(3):314-21. PubMed ID: 8721777
[TBL] [Abstract][Full Text] [Related]
12. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis.
Grubic N; Stegnar M; Peternel P; Kaider A; Binder BR
Thromb Res; 1996 Dec; 84(6):431-43. PubMed ID: 8987164
[TBL] [Abstract][Full Text] [Related]
13. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
[TBL] [Abstract][Full Text] [Related]
15. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population.
Sugano T; Tsuji H; Masuda H; Nakagawa K; Nishimura H; Kasahara T; Yoshizumi M; Nakahara Y; Kitamura H; Yamada K; Yoneda M; Maki K; Tatsumi T; Azuma A; Nakagawa M
Blood Coagul Fibrinolysis; 1998 Mar; 9(2):201-4. PubMed ID: 9622220
[TBL] [Abstract][Full Text] [Related]
19. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.
Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Miletich JP
Circulation; 1997 Jan; 95(1):59-62. PubMed ID: 8994417
[TBL] [Abstract][Full Text] [Related]
20. Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.
Rossaak JI; Van Rij AM; Jones GT; Harris EL
J Vasc Surg; 2000 May; 31(5):1026-32. PubMed ID: 10805895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
